Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Completed 11Recruiting 5Unknown 2Terminated 2Active not recruiting 2Withdrawn 1Not yet recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Tumor-Agnostic 1Thoracic 1Gastrointestinal 1

Conditions

Stress Disorders, Post-Traumatic 1Pain 1Neoplasms 1Lung Neoplasms 1Digestive System Neoplasms 1Depression 1Anxiety Disorders 1

Interventions

Cyclophosphamide 390Carboplatin 344Gemcitabine 332pembrolizumab 329Cisplatin 328Paclitaxel 297Radiotherapy 296Docetaxel 286Bevacizumab 253Rituximab 234Capecitabine 223Nivolumab 220Dexamethasone 206Fluorouracil 190fludarabine 177Oxaliplatin 177Pemetrexed 153Doxorubicin 153Irinotecan 148Leucovorin 144Etoposide 144Cytarabine 133Cetuximab 129Bortezomib 129fludarabine phosphate 128Lenalidomide 126Erlotinib Hydrochloride 120Filgrastim 119Temozolomide 113Radiosurgery 113

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Terminated × Meditation × Clear all
NCT02170350 2025-04-29

Brief Mindful Meditation Practice in Improving Quality of Life in Patients With Cancer Undergoing Radiation Therapy

Thomas Jefferson University

Phase NA Terminated
17 enrolled
Tumor-Agnostic

Neoplasms

NCT01939210 2018-05-18

Meditation-Based Breathing Training in Improving Target Motion Management and Reducing Distress in Patients With Abdominal or Lung Cancer Undergoing Radiation Therapy

Albert Einstein College of Medicine

Phase NA Terminated
17 enrolled
GastrointestinalThoracic

Anxiety Disorders, Depression, Digestive System Neoplasms, Lung Neoplasms, Pain, Stress Disorders, Post-Traumatic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡